Enrolled Senate Bill (S)
Authored by: Sen. Brandt Hershman, Sen. Ronald Grooms
Co-Authors: Sen. Jean Breaux
Sponsors: Rep. Edward Clere
  • Sen. Brandt Hershman
    Sen. Brandt Hershman

    Author

  • Sen. Ronald Grooms
    Sen. Ronald Grooms

    Author

  • Sen. Jean Breaux
    Sen. Jean Breaux

    Co-Author

  • Rep. Edward Clere
    Rep. Edward Clere

    Sponsor

  • Rep. Mara Candelaria Reardon
    Rep. Mara Candelaria Reardon

    Co-Sponsor

  • Rep. Steven Davisson
    Rep. Steven Davisson

    Co-Sponsor

  • Rep. Robin Shackleford
    Rep. Robin Shackleford

    Co-Sponsor

DIGEST

Biosimilar drugs. Allows a pharmacist to substitute an interchangeable biosimilar product for a prescribed biological product if certain conditions are met. Requires a pharmacist to record in a certain manner the name and manufacturer of a biologic product that the pharmacist is dispensing not later than ten days after dispensing the biologic product. Requires the board of pharmacy to maintain a link on the board's website to the current list of all biological products that are determined by the United States Food and Drug Administration to be interchangeable with a specific reference biological product. Allows the board of pharmacy to adopt rules. ... Provides that a written or electronic prescription for a biological product must comply with the existing prescription form requirements. (The introduced version of this bill was prepared by the health finance commission.)